Business Process Management

PRODUCTS

  • Small molecule drugs are chemical compounds that have a low molecular weight, typically below 900 daltons. Due to their small size and chemical characteristics, small molecule drugs are well-suited to enter the gastrointestinal tract and quickly absorb into the bloodstream. Additionally, they can easily pass through cell membranes to exert their therapeutic effects. Today it’s estimated that small molecules account for 90% of drugs in the market. One reason they’re so popular and patient-friendly is that they can be taken orally, which makes them convenient for all ages.

  • Standalone, turnkey, process ready cGMP modular cleanrooms

    Germfree cGMP modular cleanrooms are a platform solution that unlock standalone manufacturing capacity for a variety of applications. Serving processes from cell therapy to sterile fill-finish manufacturing cGMP modular facilities offer unmatched finishes, layout flexibility, controls, timeline assurance, and cost benefits for the biopharmaceutical industry. This is why Germfree has been chosen by 12 of the top 20 biopharmaceutical companies as their modular cleanroom providers.

    Modular cleanrooms highlights: Biopharma, International building codes, IBC, NFPA, ISO. BSL-2 BMBL, FDA, EMA, cGMP compliant

    Applications: Aseptic Filling, Cell Therapy, Gene Therapy, Viral Vector, Plasmids

  • Industry-leading formulation services for small molecules designed to support every stage of development—from preclinical through clinical trials to commercialization. Altasciences' expertise in solubility enhancement, bioavailability optimization, and a wide range of delivery technologies ensures a seamless path to market.

  • If you need robust and reliable fill-finish equipment that causes minimal disruption to your existing footprint, the Hull i-Dositecno LI Versa-Line™ Pharmaceutical Filling equipment is here to help! Accessibility from one side means you can install at the wall for a linear filling and capping system that fits neatly into any space.

  • Industry leader in preclinical safety assessments across various therapeutic areas. 30+ years of experience in full range of in vivo non-GLP and GLP studies in both rodent and non-rodent species.

WHITE PAPERS AND CASE STUDIES

NEWS